Evidence map›Paper›PMID 2527255›Full record

ArticleThe Journal of clinical investigation1989

In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

R P Kimberly, J C Edberg, L T Merriam, S B Clarkson, J C Unkeless, R P Taylor

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Immune complex processing in C1q-deficient mice.Clinical and experimental immunology · 2001
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R P KimberlyHospital for Special Surgery, Cornell University Medical College, New York 10021.
J C Edberg
L T Merriam
S B Clarkson
J C Unkeless
R P Taylor
Hospital for Special Surgery · US

Funding

MONONUCLEAR PHAGOCYTE FUNCTION IN IMMUNOLOGIC DISEASESR01AR033062 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 1986 to 2010
$3.8M
FC RECEPTOR STRUCTURE AND FUNCTIONR37AI024322 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI UNKELESS, JAY C · 1996 to 2002
$1.1M
STUDIES OF FC AND C3B RECEPTOR STURCTURE AND FUNCTIONR01AI024322 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI UNKELESS, JAY C · 1986 to 1995
–
CHARACTERIZATION OF PATHOGENIC DNA - ANTIBODY COMPLEXESR01AR024083 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI TAYLOR, RONALD PAUL · 1986 to 1990
–
NIAID NIH HHS AI-24322NIAMS NIH HHS AR-24083NIAMS NIH HHS AR-33062
6 · The paper itself

Abstract

We used soluble, C-fixing antibody/dsDNA IC to investigate immune complex (IC) handling and erythrocyte (E)-to-phagocyte transfer in chimpanzees. IC bound efficiently to chimpanzee E in vitro and showed minimal release with further in vitro incubation in the presence of serum in EDTA (less than or equal to 15% within 1 h). These IC also bound rapidly to E in vivo (70-80% binding within 1 min) and did not show detectable release from E in the peripheral circulation after infusion in vivo (less than or equal to 2% within 1 h). Despite such slow C-mediated release of IC from E, IC were rapidly stripped from E by the mononuclear phagocyte system (T50 for E-IC1500 = 5 min) without sequestration of E. Treatment of the chimpanzees with the anti-Fc gamma RIII MAb 3G8 impaired the clearance of infused IC. This effect was most evident on the fraction of IC500 which did not bind to E and which presumably had captured less C3b (pre-MAb 3G8 T50: 45 min vs. post-MAb 3G8 T50: 180 min). With IC bound in vitro to E before infusion, anti-Fc gamma RIII MAb treatment led to significant amounts of non-E bound IC detectable in the circulation. Thus, the anti-Fc gamma RIII MAb appeared to interfere with the ability of fixed tissue mononuclear phagocytes to take up/or retain IC after their release from E. Both rapid stripping of IC from E, despite slow complement-mediated release of IC from E in the peripheral circulation, and blockade of IC clearance with anti-Fc gamma RIII MAb indicate that the interaction of IC with the fixed tissue phagocyte involves qualitatively different mechanisms than the interaction of IC with E. Fc gamma receptors appear to play an important role in the transfer and retention of IC by the phagocyte.

Indexed as

Complement Fixation TestsAnimalsAntigen-Antibody ComplexAntigens, DifferentiationDNAErythrocytesErythrocyte TransfusionImmunoglobulin GInfusions, IntravenousMetabolic Clearance RateModels, BiologicalPan troglodytesReceptors, ComplementReceptors, FcReceptors, IgGSolubilityAntigen-Antibody ComplexAntigens, DifferentiationDNAImmunoglobulin GReceptors, ComplementReceptors, FcReceptors, IgG

Identifiers

PMID2527255
PMCPMC329742
OpenAlexW2065237510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.